Bipartisan legislators introduced HR6799, the BRIDGE for Young-Onset Alzheimer’s Disease Act of 2025 on Wednesday.

A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show how education level relates to ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

A new study presents robust evidence on the role of lysophosphatidylcholines (LPCs) in the onset of Alzheimer's disease.

The findings add to previous research at CU Anschutz which found that Alzheimer’s patients given Leukine showed improvement ...

A new study identifies certain neurotoxins responsible for brain inflammation common to early on-set Alzheimer's disease and ...

Major Alzheimer’s breakthroughs in 2025 include new FDA-approved blood tests, at-home treatments, and lifestyle research showing cognitive benefits for older adults.

A small study shows cognitive improvements in patients with AD following treatment with an in-home gamma sensory stimulation ...

Scientists at Northern Arizona University are developing a promising new way to detect Alzheimer’s disease earlier than ever before—by tracking how the brain uses sugar. Using tiny particles in the ...

People given the herpes medication valacyclovir actually experienced worse cognitive decline than those given a placebo.

Alzheimer’s is often diagnosed late in the course of the disease, which is why researchers have been investigating whether a ...

Blood tests for Alzheimer’s disease are becoming more accurate, but researchers stress the need for caution and further study.